ZH3D Academy – Preclinical Drug Development Course
Registration is now open
We are pleased to invite you to the ZH3D Academy course series on Preclinical Drug Development,
a three-part course designed to provide practical and regulatory insights into nonclinical drug
development with focus on early stages.
Course dates
Day 1 | Thursday, 15 October 2026 | On-site (University of Zurich, Centre) | 13:00–16:45
Day 2 | Thursday, 22 October 2026 | Online | 13:00–17:30
Day 3 | Thursday, 29 October 2026 | On-site (University of Zurich, Centre) | 13:00–16:45
Course format
- Three-part course series
- Participation is only possible for the complete course package
- Language: English
- Limited to 25 participants
- Course fee:
- External Participants: CHF 1’485
- UMZH Employees: CHF 1’035
- UMZH Students: CHF 735
Key topics
- Regulatory and quality aspects of nonclinical drug development
- Nonclinical drug development across different therapeutic modalities
- Nonclinical studies required for first-in-human clinical trial
- Practical guidance and how to avoid common pitfalls
Course lead
Dr. med. vet. Lisa Fischer, ERT
Head ZH3D Academy and Nonclinical Expert
Registration
Register by 7 October 2026
Places will be allocated on a first come, first served basis.
A waiting list will be maintained once capacity is reached.
If you are interested, we encourage you to register early, as places are limited.
Best regards,
ZH3D Academy Team
Universität Zürich
ZH3D – Zurich Hub for Drug and Device Development
Kurvenstrasse 31
CH-8006 Zürich
